Back to Search Start Over

Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics.

Authors :
Zhang, Xueqing
Huang, Yamei
Song, Heliang
Canup, Brandon S.B.
Gou, Shuangquan
She, Zhigang
Dai, Fangyin
Ke, Bowen
Xiao, Bo
Source :
Journal of Controlled Release. Dec2020, Vol. 328, p454-469. 16p.
Publication Year :
2020

Abstract

Lung metastasis of breast cancer is a leading cause of cancer-related death in women. Herein, we attempted to simultaneously inhibit the growth and lung metastasis of breast cancer by delivering quercetin (QU) using LyP-1-functionalized regenerated silk fibroin-based nanoparticles (NPs). The generated LyP-1-QU-NPs had a desirable diameter (203.2 nm) and a negatively charged surface (−12.7 mV). Interestingly, these NPs exhibited intrinsic responsibilities when triggered by various stimulating factors in the tumor microenvironment (acidic pH, reactive oxygen species, and glutathione). In vitro experiments revealed that the introduction of LyP-1 to the NP surface could significantly increase their cellular uptake efficiencies by 4 T1 cells, and facilitate their accumulation in mitochondria. Moreover, LyP-1-QU-NPs showed the strongest mitochondrial damage effect among all the treatment groups. We also found that LyP-1-QU-NPs not only exhibited excellent pro-apoptotic activities but also presented strong inhibitory effects on cell mobility (migration and invasion) through anti-glycolysis and pro-autophagy. Mice experiments confirmed that LyP-1-QU-NPs could efficiently inhibit the in situ growth of breast tumors and further restrict their lung metastasis. Collectively, our results demonstrate that LyP-1-QU-NPs, which integrates the functions of tumor cell targeting, mitochondria targeting, bioresponsive drug release, pro-apoptosis, and anti-mobility, can be developed as a promising nanotherapeutic for the effective treatment of breast cancer and its lung metastasis. Triple-bioresponsive nanotherapeutics for targeted treatment of breast cancer and its lung metastasis. Unlabelled Image • LyP-1-functionalized nanoparticles (NPs) were fabricated for breast tumor-targeted delivery of quercetin (QU). • LyP-1-QU-NPs had a particle size around 203.2 nm, narrow size distribution, and negative surface charge (−12.7 mV). • LyP-1-QU-NPs exhibited intrinsic pH/H 2 O 2 /GSH-responsibilities. • LyP-1-QU-NPs showed obviously inhibitory effects on the proliferation, migration, and invasion of 4 T1 cells. • LyP-1-QU-NPs could be accumulated in tumor tissues and inhibit the growth and lung metastasis of breast cancer. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01683659
Volume :
328
Database :
Academic Search Index
Journal :
Journal of Controlled Release
Publication Type :
Academic Journal
Accession number :
147622509
Full Text :
https://doi.org/10.1016/j.jconrel.2020.08.066